Dr. Eric Singer - OncoDaily

Dr. Eric Singer Named Chair of the Kidney Cancer Association Board of Directors

The Kidney Cancer Association (KCA) has appointed Eric A. Singer, MD, MA, MS, FACS, FASCO, of The Ohio State University Comprehensive Cancer Center (OSUCCC), as Chair of the Board of Directors. His appointment was confirmed by the board during its November 2025 meeting.

Dr. Singer succeeds Dr. Bradley C. Leibovich of the Mayo Clinic, who served as Chair from 2021 and will assume the role of Transitioning Chair Emeritus for the coming year.

Involvement with KCA

Dr. Singer has previously served on the Scientific Planning Committee for the KCA’s International Kidney Cancer Symposiums and has been a member of the Medical Steering Committee since 2022. His work with the organization includes participation in mentorship programs and patient education initiatives.

Professional Background

Dr. Singer holds the Dave Lonaberger Endowed Chair in Urology, and is Professor of Urology and Bioethics, Chief of the Division of Urologic Oncology, and Director of the Urologic Oncology Fellowship at The Ohio State University Comprehensive Cancer Center.

His research focuses on developing treatments for genitourinary malignancies through clinical trials. His professional interests also include bioethics, with an emphasis on informed consent, decision-making capacity, research ethics, and surgical ethics.

Board Transition

Dr. Singer succeeds Dr. Bradley C. Leibovich, who previously led the board. Dr. Leibovich will continue to be involved as Transitioning Chair Emeritus.

 

Eric Singer

Members of the KCA’s Board of Directors, left to right: Laura Wood, Kendall Monroe, Dr. Eric Singer, Dr. Tessa Churchill, Dr. Dan George, Gretchen E. Vaughan, Joel Stern, Dr. Brian Shuch, Natalie Johnson, Dr. Laurence Albiges. Not pictured: Dr. Bradley Leibovich, Dr. Mahul Amin, Dr. Ron Bukowski, Ryan Natzke, David Perry, Shelley Robson, Ruben Ybarra.

About the Kidney Cancer Association

Founded in 1990, the Kidney Cancer Association is an international non-profit organization. It supports kidney cancer research through symposiums and grants, participates in legislative advocacy, and provides resources for patients, caregivers, and healthcare professionals.

More about oncology news on OncoDaily

Written by Nare Hovhannisyan, MD